Enrollment underway in Revance Therapeutics' late-stage DaxibotulinumtoxinA study
April 27 2021 - 08:35AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Feb 2024 to Mar 2024
Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Mar 2023 to Mar 2024